Treg-promoted New Bone Formation Through Suppressing TH17 by Secreting Interleukin-10 in Ankylosing Spondylitis.

作者: Fan Xu , Chi Guanghao , Yan Liang , Wang Jun , Wu Wei

DOI: 10.1097/BRS.0000000000003169

关键词: InterleukinInterleukin 10Ankylosing spondylitisBone resorptionPeripheral blood mononuclear cellBone remodelingBASDAIInternal medicineEndocrinologyMedicineProinflammatory cytokine

摘要: STUDY DESIGN Retrospective single-center study. OBJECTIVE We want to know whether interleukin (IL)-10-secreting regulatory T cells (Treg) promote the new bone formation (NBF) through suppressing TH17 in ankylosing spondylitis (AS). SUMMARY OF BACKGROUND DATA NBF AS is unknown. Since there are balances of remodeling human body and proinflammatory helper promoted resorption. METHODS Eighteen patients with or without (both nine cases) healthy individuals were selected demographic data, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), MRI sacroiliitis score (MRISIS), computer tomography (CTSIS) recorded. Removed hip ligament tissue lesions after arthroplasty was collected lymphocytes peripheral blood mononuclear prepared. Second, pathological section hematoxylin-eosin stain analyzed flow cytometry quantitative polymerase chain reaction analyses carried out detect levels TH17, Treg, IL-10, nuclear factor (NF)-κB, relevance between them. The effect Treg on further by using Transwell coculturing. RESULTS Compared NBF, had significantly higher CTSIS complications (P < 0.05 0.01, respectively), but lower BASDAI (3.0 ± 0.4) MRISIS (3.3 ± 0.8) 0.01 0.05, respectively) no acute inflammation HE for joint. donors, ratio TH17/Treg patient P 0.01) analysis (FCA). Furthermore, decreased indirectly coculturing FCA 0.01). Finally, IL-10 mRNA expression 0.01), NF-κB 0.05) than donors. Only correlated (r = -0.93, CONCLUSION Treg-induced secreting IL10 declining indicated development NBF. This important not only screening also control immune therapy. LEVEL EVIDENCE N/A.

参考文章(30)
Hsien-Tzung Liao, Yuh-Feng Lin, Chang-Youh Tsai, Chung-Tei Chou, Regulatory T cells in ankylosing spondylitis and the response after adalimumab treatment Joint Bone Spine. ,vol. 82, pp. 423- 427 ,(2015) , 10.1016/J.JBSPIN.2015.03.003
Luiza M. Araujo, Ingrid Fert, Quentin Jouhault, Karine Labroquère, Muriel Andrieu, Gilles Chiocchia, Maxime Breban, Increased production of interleukin-17 over interleukin-10 by treg cells implicates inducible costimulator molecule in experimental spondyloarthritis. Arthritis & Rheumatism. ,vol. 66, pp. 2412- 2422 ,(2014) , 10.1002/ART.38737
Xinyang Song, Dai Dai, Xiao He, Shu Zhu, Yikun Yao, Hanchao Gao, Jingjing Wang, Fangfang Qu, Ju Qiu, Honglin Wang, Xiaoxia Li, Nan Shen, Youcun Qian, Growth Factor FGF2 Cooperates with Interleukin-17 to Repair Intestinal Epithelial Damage Immunity. ,vol. 43, pp. 488- 501 ,(2015) , 10.1016/J.IMMUNI.2015.06.024
Sjef Van Der Linden, Hans A. Valkenburg, Arnold Cats, Evaluation of Diagnostic Criteria for Ankylosing Spondylitis Arthritis & Rheumatism. ,vol. 27, pp. 361- 368 ,(1984) , 10.1002/ART.1780270401
Abul K Abbas, Christophe Benoist, Jeffrey A Bluestone, Daniel J Campbell, Sankar Ghosh, Shohei Hori, Shuiping Jiang, Vijay K Kuchroo, Diane Mathis, Maria Grazia Roncarolo, Alexander Rudensky, Shimon Sakaguchi, Ethan M Shevach, Dario AA Vignali, Steve F Ziegler, None, Regulatory T cells: recommendations to simplify the nomenclature Nature Immunology. ,vol. 14, pp. 307- 308 ,(2013) , 10.1038/NI.2554
CHENGGONG WANG, QIANDE LIAO, YIHE HU, DA ZHONG, T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis Experimental and Therapeutic Medicine. ,vol. 9, pp. 250- 256 ,(2015) , 10.3892/ETM.2014.2046
Pamir Atagunduz, Heiner Appel, Wolfgang Kuon, Peihua Wu, Andreas Thiel, Peter-Michael Kloetzel, Joachim Sieper, HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis. Arthritis & Rheumatism. ,vol. 52, pp. 892- 901 ,(2005) , 10.1002/ART.20948
Shanshan Yin, Jianmin Zhang, Yujia Mao, Yu Hu, Lianxian Cui, Ning Kang, Wei He, Vav1-phospholipase C-γ1 (Vav1-PLC-γ1) Pathway Initiated by T Cell Antigen Receptor (TCRγδ) Activation Is Required to Overcome Inhibition by Ubiquitin Ligase Cbl-b during γδT Cell Cytotoxicity Journal of Biological Chemistry. ,vol. 288, pp. 26448- 26462 ,(2013) , 10.1074/JBC.M113.484600